The Exchange has sought clarification from Sun Pharmaceutical Industries on September 07, 2018 with reference to news appeared on: www.moneycontrol.com dated September 07, 2018 quoting ‘Sun Pharma falls 5% on report of co getting 6 observations by US FDA for Halol unit’.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.40 |
| Dr. Reddys Lab | 1220.40 |
| Cipla | 1234.65 |
| Zydus Lifesciences | 930.80 |
| Lupin | 2312.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: